Novem Group Earnings Call Transcripts
Fiscal Year 2026
-
Q3 saw a 5% revenue decline year-on-year, mainly from tooling delays, but free cash flow surged to EUR 21.3 million and net leverage improved to 1.8x. New business wins and disciplined cost control supported resilience, with a stable outlook and strong cash generation expected to continue.
-
Revenue and EBIT declined year-over-year due to market weakness, tooling delays, and external disruptions, but free cash flow and liquidity improved significantly. New business wins and disciplined cost management support stabilization, with margin recovery expected despite no near-term volume rebound.
-
Revenue declined 8% year-over-year due to tooling delays and industry headwinds, but free cash flow and working capital improved. Profitability was pressured, though new orders and cost controls provide some optimism for the second half.
Fiscal Year 2025
-
Revenue fell 14.8% year-over-year to EUR 541.5 million, with adjusted EBIT margin at 9% and strong Q4 free cash flow. Restructuring, cost controls, and new program wins offset market headwinds, while midterm margin guidance of 11%-12% is maintained.
-
Q3 revenue fell 11% year-over-year to EUR 124 million, with adjusted EBIT margin at 8.1%. Market headwinds persist, prompting a reduction in midterm EBIT margin guidance to 11–12%. Americas remained stable, while Europe and Asia declined.
-
Revenue and EBIT declined sharply year-over-year due to weak demand and external disruptions, with Europe and Asia most affected. Americas remained resilient, and future growth is expected from a major US EV manufacturer contract ramping up in Q4.
-
Revenue fell 20% year-over-year to EUR 140 million, with Europe seeing the largest decline, but EBIT margin held at 10.1% due to cost controls. Americas outperformed with a 19.6% margin, and a major contract was secured for the Mercedes GLE in China.